239 related articles for article (PubMed ID: 23173980)
21. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
[TBL] [Abstract][Full Text] [Related]
22. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
23. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.
Soltys DT; Rocha CR; Lerner LK; de Souza TA; Munford V; Cabral F; Nardo T; Stefanini M; Sarasin A; Cabral-Neto JB; Menck CF
Hum Mutat; 2013 Mar; 34(3):481-9. PubMed ID: 23255472
[TBL] [Abstract][Full Text] [Related]
24. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
[TBL] [Abstract][Full Text] [Related]
25. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
27. Validation of XP-C pathogenic variations in archival material from a live XP patient.
McDaniel LD; Rivera-Begeman A; Doughty AT; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):115-20. PubMed ID: 17084680
[TBL] [Abstract][Full Text] [Related]
28. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
29. A novel mutation in the XPA gene results in two truncated protein variants and leads to a severe XP/neurological symptoms phenotype.
Lehmann J; Schubert S; Schäfer A; Laspe P; Haenssle HA; Ohlenbusch A; Gratchev A; Emmert S
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2479-82. PubMed ID: 25393472
[TBL] [Abstract][Full Text] [Related]
30. XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.
Khan SG; Oh KS; Emmert S; Imoto K; Tamura D; Digiovanna JJ; Shahlavi T; Armstrong N; Baker CC; Neuburg M; Zalewski C; Brewer C; Wiggs E; Schiffmann R; Kraemer KH
DNA Repair (Amst); 2009 Jan; 8(1):114-25. PubMed ID: 18955168
[TBL] [Abstract][Full Text] [Related]
31. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
[TBL] [Abstract][Full Text] [Related]
32. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
33. [Xeroderma pigmentosum. A study in 40 Algerian patients].
Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
[TBL] [Abstract][Full Text] [Related]
34. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
35. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC.
Sands AT; Abuin A; Sanchez A; Conti CJ; Bradley A
Nature; 1995 Sep; 377(6545):162-5. PubMed ID: 7675084
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of UV-induced mutation spectra in human XP-D/ERCC2 gene-mutated xeroderma pigmentosum and trichothiodystrophy cells.
Marionnet C; Benoit A; Benhamou S; Sarasin A; Stary A
J Mol Biol; 1995 Oct; 252(5):550-62. PubMed ID: 7563073
[TBL] [Abstract][Full Text] [Related]
39. Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC.
Bernardes de Jesus BM; Bjørås M; Coin F; Egly JM
Mol Cell Biol; 2008 Dec; 28(23):7225-35. PubMed ID: 18809580
[TBL] [Abstract][Full Text] [Related]
40. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
Marchetto MC; Correa RG; Menck CF; Muotri AR
J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
